Back
Principal Financial Group Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
46
PFG
Principal Financial Group
Last Price:
80.03
Seasonality Move:
4.65%
Sell
38
RARE
Ultragenyx Pharmaceutical
Last Price:
39.58
Seasonality Move:
3.65%
Sell
46
Principal Financial Group (PFG)
is a Sell
Is Principal Financial Group a Buy, Sell or Hold?
- The current Principal Financial Group [PFG] share price is $80.28. The Score for PFG is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- PFG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $38.02. The Score for RARE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PFG Stock Price Chart
What is Principal Financial Group's stock price today?
-
The Principal Financial Group share price today is $80.28
The current trend is relatively stagnant and PFG is experiencing buying pressure, which is a positive indicator for future bullish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $38.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.
PFG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1 | Sell |
Relative Strength Index (14 RSI): | 51.14 | Buy |
Chaikin Money Flow: | 1069756 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (78.33 - 83.07) | Sell |
Bollinger Bands (100): | (78.78 - 83.4) | Sell |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.74 | Sell |
Relative Strength Index (14 RSI): | 40.05 | Sell |
Chaikin Money Flow: | 76134 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (39.06 - 42.34) | Sell |
Bollinger Bands (100): | (41.13 - 48.85) | Sell |
PFG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 78.22 | Buy |
20-day SMA: | 79.82 | Buy |
50-day SMA: | 80.88 | Sell |
200-day SMA: | 77.63 | Buy |
8-day EMA: | 78.72 | Buy |
20-day EMA: | 79.63 | Buy |
50-day EMA: | 80.65 | Sell |
200-day EMA: | 79.15 | Buy |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.68 | Sell |
20-day SMA: | 40.48 | Sell |
50-day SMA: | 42.18 | Sell |
200-day SMA: | 42.45 | Sell |
8-day EMA: | 39.81 | Sell |
20-day EMA: | 40.64 | Sell |
50-day EMA: | 42.13 | Sell |
200-day EMA: | 43.5 | Sell |
Principal Financial Group Earnings Growth & PFG Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.37 per share, an increase next quarter of $0.11 per share, an increase this year of $1.08 per share, and an increase next year of $0.96 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.
Principal Financial Group Technical Analysis
Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |